TACE Treatment in Patients with Sorafenib-treated Unresectable Hepatocellular Carcinoma in Clinical Practice: Final Analysis of GIDEON

Jean-François H. Geschwind; Masatoshi Kudo; Jorge A. Marrero; Alan P. Venook; Xiao-Ping Chen; Jean-Pierre Bronowicki; Lucy Dagher; Junji Furuse; Laura Ladrón de Guevara; Christos N. Papandreou; Arun J. Sanyal; Tadatoshi Takayama; Sheng-Long Ye; Seung Kew Yoon; Keiko Nakajima; Robert Lehr; Stephanie Heldner; Riccardo Lencioni

doi:10.1148/radiol.2015150667

Related publications

Article2016

Safety and efficacy of sorafenib in Japanese patients with hepatocellular carcinoma in clinical practice: a subgroup analysis of GIDEON

Masatoshi Kudo, Masafumi Ikeda, Tadatoshi Takayama, Kazushi Numata, Namiki Izumi, Junji Furuse, Takuji Okusaka, Masumi Kadoya, Satoshi Yamashita, Yuichiro Ito, Norihiro Kokudo

Article2012

Survival of patients with hepatocellular carcinoma treated by transarterial chemoembolisation (TACE) using Drug Eluting Beads. Implications for clinical practice and trial design

Marta Burrel, María Reig, Alejandro Forner, Marta Barrufet, Carlos Rodríguez de Lope, Silvia Tremosini, Carmen Ayuso, Josep M. Llovet, María Isabel Real, Jordi Bruix

Journal of Hepatology

Article2017

Hepatic Function during Repeated TACE Procedures and Prognosis after Introducing Sorafenib in Patients with Unresectable Hepatocellular Carcinoma: Multicenter Analysis

Atsushi Hiraoka, Takashi Kumada, Masatoshi Kudo, Masashi Hirooka, Yohei Koizumi, Yoichi Hiasa, Kazuto Tajiri, Hidenori Toyoda, Toshifumi Tada, Hironori Ochi, Koji Joko, Noritomo Shimada, Akihiro Deguchi, Toru Ishikawa, Michitaka Imai, Kunihiko Tsuji, Kojiro Michitaka

Article2018

Outcomes of patients (pts) with hepatocellular carcinoma (HCC) treated with transarterial chemoembolization (TACE): Global OPTIMIS final analysis.

Markus Peck‐Radosavljevic, Masatoshi Kudo, Jean‐Luc Raoul, Han Chu Lee, Thomas Decaens, Jeong Heo, Shi‐Ming Lin, Hong Shan, Yefa Yang, Inga Bayh, Keiko Nakajima, Ann‐Lii Cheng

Article2015

Effectiveness of Sorafenib in Patients with Transcatheter Arterial Chemoembolization (TACE) Refractory and Intermediate-Stage Hepatocellular Carcinoma

Tadaaki Arizumi, Kazuomi Ueshima, Tomohiro Minami, Masashi Kono, Hirokazu Chishina, Masahiro Takita, Satoshi Kitai, Tatsuo Inoue, Norihisa Yada, Satoru Hagiwara, Yasunori Minami, Toshiharu Sakurai, Naoshi Nishida, Masatoshi Kudo